Alpha 2.0
Login Register
» Articles » PMID: 31360038

Expert Consensus on the Management of Telogen Effluvium in India

Overview
Journal Int J Trichology
Date 2019 Jul 31
PMID 31360038
Citations 11
Authors
Venkataram Mysore
Anchala Parthasaradhi
R D Kharkar
A K Ghoshal
Anil Ganjoo
G Ravichandran
Abir Saraswat
Yogesh Shah
Mohan Singh
T J Remadevi
Prachi Matte
Affiliations
Soon will be listed here.
Abstract

Alopecia, a frequently reported problem, severely impacts the quality of life of patients and is often associated with loss of confidence and low self-esteem. Several conditions such as telogen effluvium (TE), anagen effluvium, diffuse type of alopecia areata, female pattern hair loss, hair shaft abnormalities, loose anagen hair syndrome, and congenital atrichia or hypotrichosis are associated with hair loss. The actual prevalence rate of TE is not reported since most cases are subclinical in nature. Further, since women get more distressed by hair fall and promptly seek treatment, they tend to be over-represented. However, both genders can suffer from this condition if triggering factors are present. This consensus paper was developed by taking into account opinions of renowned experts in the field and is hoped to serve as an evidence-based platform for selecting efficacious and safe therapy for patients with TE. This review presents a synopsis of the key opinions of experts on all aspects of treatment and effective management of this condition.

Citing Articles

A Well-Tolerated Hair Serum Containing New Natural Active Ingredients Reduced Hair Loss and Improved Quality of Life in Women With Chronic Telogen Effluvium: A 16-Week Controlled Study.

Turlier V, Froliger M, Ribet V, Mengeaud V, Reygagne P J Cosmet Dermatol. 2024; 23 Suppl 5:12-21.

PMID: 39606909 PMC: 11603399. DOI: 10.1111/jocd.16656.

The Contribution of the Intestinal Microbiota to the Celiac Disease Pathogenesis along with the Effectiveness of Probiotic Therapy.

Zolnikova O, Dzhakhaya N, Bueverova E, Sedova A, Kurbatova A, Kryuchkova K Microorganisms. 2023; 11(12).

PMID: 38137992 PMC: 10745538. DOI: 10.3390/microorganisms11122848.

Micronutrient Deficiencies and Digital Computerized Phototrichogram Analysis in Telogen Effluvium: a Retrospective Correlation Study in a Tertiary Medical Center.

Arslan H, Gunduz O Dermatol Pract Concept. 2023; 13(3).

PMID: 37557102 PMC: 10412014. DOI: 10.5826/dpc.1303a202.

[Review of the post-COVID-19 syndrome associated to acute telogen effluvium].

Chavez-Chavira G Rev Med Inst Mex Seguro Soc. 2023; 61(4):496-501.

PMID: 37540705 PMC: 10521875. DOI: 10.5281/zenodo.8200471.

Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium.

Popescu M, Berteanu M, Beiu C, Popa L, Mihai M, Iliescu M Clin Cosmet Investig Dermatol. 2022; 15:735-743.

PMID: 35497690 PMC: 9042074. DOI: 10.2147/CCID.S359052.

References
1.
Messenger A, Rundegren J . Minoxidil: mechanisms of action on hair growth. Br J Dermatol. 2004; 150(2):186-94. DOI: 10.1111/j.1365-2133.2004.05785.x. View
2.
Shrivastava S . Diffuse hair loss in an adult female: approach to diagnosis and management. Indian J Dermatol Venereol Leprol. 2009; 75(1):20-7. DOI: 10.4103/0378-6323.45215. View
3.
Harrison S, Bergfeld W . Diffuse hair loss: its triggers and management. Cleve Clin J Med. 2009; 76(6):361-7. DOI: 10.3949/ccjm.76a.08080. View
4.
Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S . Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012; 6(2):130-6. DOI: 10.2174/187221312800166859. View
5.
Grover C, Khurana A . Telogen effluvium. Indian J Dermatol Venereol Leprol. 2013; 79(5):591-603. DOI: 10.4103/0378-6323.116731. View